Hemostasis and Thrombosis in Pregnancy

  • Molly M. Daughety
  • Bethany T. Samuelson Bannow


In developing countries, the leading cause of maternal death is postpartum hemorrhage, and in industrialized nations, the leading cause of maternal death is venous thromboembolism. Furthermore, there are several other hematologic maladies that may present additional challenges in maintaining the health and well-being of the mother and child during pregnancy, delivery, and the postpartum period. In this chapter, we discuss the hematologic disease states that most commonly complicate pregnancy and offer insight into the diagnosis and management of these conditions.


Pregnancy Thrombocytopenia Immune thrombocytopenic purpura Thrombotic microangiopathy Acute fatty liver of pregnancy Postpartum hemorrhage Von Willebrand disease Hemophilia Venous thromboembolism Congenital thrombophilias Antiphospholipid syndrome 

Suggested Reading

  1. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology. 1990;99(2):443–6.PubMedCrossRefGoogle Scholar
  2. Andersen BS, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J. The cumulative incidence of venous thromboembolism during pregnancy and puerperium--an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol Scand. 1998;77(2):170–3.PubMedCrossRefGoogle Scholar
  3. Andrew M, Boneu B, Cade J, Cerskus AL, Hirsh J, Jefferies A, et al. Placental transport of low molecular weight heparin in the pregnant sheep. Br J Haematol. 1985;59(1):103–8.PubMedCrossRefGoogle Scholar
  4. Bar J, Cohen-Sacher B, Hod M, Blickstein D, Lahav J, Merlob P. Low-molecular-weight heparin for thrombophilia in pregnant women. Int J Gynaecol Obstet. 2000;69(3):209–13.PubMedCrossRefGoogle Scholar
  5. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S–736S.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):92–128.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Beyer-Westendorf J, Michalski F, Tittl L, Middeldorp S, Cohen H, Abdul Kadir R, et al. Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting. Thromb Haemost. 2016;116(4):651–8.PubMedGoogle Scholar
  8. Bleker SM, Buchmuller A, Chauleur C, Ni Ainle F, Donnelly J, Verhamme P, et al. Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: rationale and design of the Highlow study, a randomised trial of two doses. Thromb Res. 2016;144:62–8.PubMedCrossRefGoogle Scholar
  9. Boehlen F, Hohlfeld P, Extermann P, Perneger TV, de Moerloose P. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol. 2000;95(1):29–33.PubMedGoogle Scholar
  10. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):153–68.PubMedCrossRefGoogle Scholar
  11. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development G. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax. 2003;58(6):470–83.CrossRefGoogle Scholar
  12. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 1993;329(20):1463–6.PubMedCrossRefGoogle Scholar
  13. Canigral C, Moscardo F, Castro C, Pajares A, Lancharro A, Solves P, et al. Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome. Ann Hematol. 2014;93(8):1421–2.PubMedGoogle Scholar
  14. Chalmers E, Williams M, Brennand J, Liesner R, Collins P, Richards M, et al. Guideline on the management of haemophilia in the fetus and neonate. Br J Haematol. 2011;154(2):208–15.PubMedCrossRefGoogle Scholar
  15. Chan WS, Rey E, Kent NE, Group VTEiPGW, Chan WS, Kent NE, et al. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can. 2014;36(6):527–53.PubMedCrossRefGoogle Scholar
  16. Committee on Practice B-O. Practice bulletin no. 183: postpartum hemorrhage. Obstet Gynecol. 2017;130(4):e168–e86.CrossRefGoogle Scholar
  17. Dimitrakakis C, Papageorgiou P, Papageorgiou I, Antzaklis A, Sakarelou N, Michalas S. Absence of transplacental passage of the low molecular weight heparin enoxaparin. Haemostasis. 2000;30(5):243–8.PubMedGoogle Scholar
  18. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 2007;298(3):317–23.PubMedCrossRefGoogle Scholar
  19. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005;(2):CD002859.Google Scholar
  20. George JN, Nester CM, McIntosh JJ. Syndromes of thrombotic microangiopathy associated with pregnancy. Hematology Am Soc Hematol Educ Program. 2015;2015:644–8.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood. 2013;121(1):38–47.PubMedCrossRefGoogle Scholar
  22. Gherman RB, Goodwin TM, Leung B, Byrne JD, Hethumumi R, Montoro M. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol. 1999;94(5 Pt 1):730–4.PubMedGoogle Scholar
  23. Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet. 1999;353(9160):1258–65.PubMedCrossRefGoogle Scholar
  24. Haeri S, Dildy GA. Maternal mortality from hemorrhage. Semin Perinatol. 2012;36(1):48–55.PubMedCrossRefGoogle Scholar
  25. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009;9:8.PubMedPubMedCentralCrossRefGoogle Scholar
  26. Hayashino Y, Goto M, Noguchi Y, Fukui T. Ventilation-perfusion scanning and helical CT in suspected pulmonary embolism: meta-analysis of diagnostic performance. Radiology. 2005;234(3):740–8.PubMedCrossRefGoogle Scholar
  27. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143(10):697–706.PubMedCrossRefGoogle Scholar
  28. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition). Reg Anesth Pain Med. 2010;35(1):64–101.PubMedCrossRefGoogle Scholar
  29. Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study. Am J Obstet Gynecol. 2008;198(2):233 e1–7.CrossRefGoogle Scholar
  30. James A. Committee on Practice B-O. Practice bulletin no. 123: thromboembolism in pregnancy. Obstet Gynecol. 2011;118(3):718–29.PubMedCrossRefGoogle Scholar
  31. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194(5):1311–5.PubMedCrossRefGoogle Scholar
  32. James AH, Rhee E, Thames B, Philipp CS. Characterization of antithrombin levels in pregnancy. Thromb Res. 2014;134(3):648–51.PubMedCrossRefGoogle Scholar
  33. James AH, Konkle BA, Kouides P, Ragni MV, Thames B, Gupta S, et al. Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis. Haemophilia. 2015;21(1):81–7.PubMedCrossRefGoogle Scholar
  34. Kadir RA, Davies J, Winikoff R, Pollard D, Peyvandi F, Garagiola I, et al. Pregnancy complications and obstetric care in women with inherited bleeding disorders. Haemophilia. 2013;19(Suppl 4):1–10.PubMedCrossRefGoogle Scholar
  35. Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MS. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370(14):1307–15.PubMedPubMedCentralCrossRefGoogle Scholar
  36. Kelly RJ, Hochsmann B, Szer J, Kulasekararaj A, de Guibert S, Roth A, et al. Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2015;373(11):1032–9.PubMedCrossRefGoogle Scholar
  37. Knight M, Nelson-Piercy C, Kurinczuk JJ, Spark P, Brocklehurst P, System UKOS. A prospective national study of acute fatty liver of pregnancy in the UK. Gut. 2008;57(7):951–6.PubMedCrossRefGoogle Scholar
  38. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–69, 69a-69k.PubMedCrossRefGoogle Scholar
  39. Kujovich JL. von Willebrand disease and pregnancy. J Thromb Haemost. 2005;3(2):246–53.PubMedCrossRefGoogle Scholar
  40. Leung AN, Bull TM, Jaeschke R, Lockwood CJ, Boiselle PM, Hurwitz LM, et al. An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy. Am J Respir Crit Care Med. 2011;184(10):1200–8.PubMedCrossRefGoogle Scholar
  41. Lindqvist P, Dahlback B, Marsal K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999;94(4):595–9.PubMedGoogle Scholar
  42. Lu E, Shatzel JJ, Salati J, DeLoughery TG. The safety of low-molecular-weight heparin during and after pregnancy. Obstet Gynecol Surv. 2017;72(12):721–9.PubMedCrossRefGoogle Scholar
  43. Ludlam CA, Pasi KJ, Bolton-Maggs P, Collins PW, Cumming AM, Dolan G, et al. A framework for genetic service provision for haemophilia and other inherited bleeding disorders. Haemophilia. 2005;11(2):145–63.PubMedCrossRefGoogle Scholar
  44. Mak A, Cheung MW, Cheak AA, Ho RC. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxford). 2010;49(2):281–8.CrossRefGoogle Scholar
  45. McColl MD, Ramsay JE, Tait RC, Walker ID, McCall F, Conkie JA, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost. 1997;78(4):1183–8.PubMedGoogle Scholar
  46. McLintock C, Brighton T, Chunilal S, Dekker G, McDonnell N, McRae S, et al. Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period. Aust N Z J Obstet Gynaecol. 2012;52(1):14–22.PubMedCrossRefGoogle Scholar
  47. Michel M, Novoa MV, Bussel JB. Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy. Br J Haematol. 2003;123(1):142–6.PubMedCrossRefGoogle Scholar
  48. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.PubMedCrossRefGoogle Scholar
  49. Ockner SA, Brunt EM, Cohn SM, Krul ES, Hanto DW, Peters MG. Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology. 1990;11(1):59–64.PubMedCrossRefGoogle Scholar
  50. Orme ML, Lewis PJ, de Swiet M, Serlin MJ, Sibeon R, Baty JD, et al. May mothers given warfarin breast-feed their infants? Br Med J. 1977;1(6076):1564–5.PubMedPubMedCentralCrossRefGoogle Scholar
  51. Polak JF, Wilkinson DL. Ultrasonographic diagnosis of symptomatic deep venous thrombosis in pregnancy. Am J Obstet Gynecol. 1991;165(3):625–9.PubMedCrossRefGoogle Scholar
  52. Price HV, Salaman JR, Laurence KM, Langmaid H. Immunosuppressive drugs and the foetus. Transplantation. 1976;21(4):294–8.PubMedCrossRefGoogle Scholar
  53. Quiroz R, Kucher N, Zou KH, Kipfmueller F, Costello P, Goldhaber SZ, et al. Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. JAMA. 2005;293(16):2012–7.PubMedCrossRefGoogle Scholar
  54. Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, et al. Platelet counts during pregnancy. N Engl J Med. 2018;379(1):32–43.PubMedPubMedCentralCrossRefGoogle Scholar
  55. Richter C, Sitzmann J, Lang P, Weitzel H, Huch A, Huch R. Excretion of low molecular weight heparin in human milk. Br J Clin Pharmacol. 2001;52(6):708–10.PubMedPubMedCentralCrossRefGoogle Scholar
  56. Riely CA, Latham PS, Romero R, Duffy TP. Acute fatty liver of pregnancy. A reassessment based on observations in nine patients. Ann Intern Med. 1987;106(5):703–6.PubMedCrossRefGoogle Scholar
  57. Rodger MA, Hague WM, Kingdom J, Kahn SR, Karovitch A, Sermer M, et al. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. Lancet. 2014;384(9955):1673–83.PubMedCrossRefGoogle Scholar
  58. Russell JR, Stabin MG, Sparks RB, Watson E. Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. Health Phys. 1997;73(5):756–69.PubMedCrossRefGoogle Scholar
  59. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84(2):160–74.PubMedCrossRefGoogle Scholar
  60. Sainio S, Kekomaki R, Riikonen S, Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand. 2000;79(9):744–9.PubMedCrossRefGoogle Scholar
  61. Shakur H, Elbourne D, Gulmezoglu M, Alfirevic Z, Ronsmans C, Allen E, et al. The WOMAN trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010;11:40.PubMedPubMedCentralCrossRefGoogle Scholar
  62. Simpson EL, Lawrenson RA, Nightingale AL, Farmer RD. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG. 2001;108(1):56–60.PubMedGoogle Scholar
  63. Tuohy E, Litt E, Alikhan R. Treatment of patients with von Willebrand disease. J Blood Med. 2011;2:49–57.PubMedPubMedCentralGoogle Scholar
  64. Victora CG, Requejo JH, Barros AJ, Berman P, Bhutta Z, Boerma T, et al. Countdown to 2015: a decade of tracking progress for maternal, newborn, and child survival. Lancet. 2016;387(10032):2049–59.PubMedCrossRefGoogle Scholar
  65. Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol. 1990;6:217–46.PubMedCrossRefGoogle Scholar
  66. Winer-Muram HT, Boone JM, Brown HL, Jennings SG, Mabie WC, Lombardo GT. Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT. Radiology. 2002;224(2):487–92.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Molly M. Daughety
    • 1
  • Bethany T. Samuelson Bannow
    • 1
    • 2
  1. 1.Division of Hematology and OncologyDuke University Medicine CenterDurhamUSA
  2. 2.The Hemophilia CenterOregon Health & Science UniversityPortlandUSA

Personalised recommendations